COVID-19 IN PEDIATRICS AND OUR EXPERIENCES

Introduction: The purpose of the research was to analyze the treatment of children during the SARS CoV-2 epidemic in the red zone of of the Pediatric Clinic in Ljubljana. Methods: A quantitative, non-experimental type of research was used. All hospitalized children from October to March 2022 were included. Data were obtained using the Clinical information system. results: 203 children, (113 (55.7%) boys and 90 (44.3%) girls) were included. The majority were aged 6–12 years 58 (26.1%). Most SARS-CoV-2 positive children (93,6%) were hospitalized in the red zone of Admission and Triage Department red zone and 10 (6.4%) in the another departments. The majority were hematological oncology patients (22.7%), and the leastowest number of children was in the field of allergology, rheumatology and clinical immunology 3%. Thirty-nine (19.2%) children received Sotrovimab, 24 (11.8%) Regencov and Remdesevir 12 (5.90%). Discusion: During the SARS-CoV-2 epidemic, work at the Pediatric Clinic has fully adapted to ensure safe management of children despite the reduced scope of work. Treatment of children with cancer, newborns, and other children with serious acute or chronically ill children from all over Slovenia were treated without interruption in the red zone of the Pediatric clinic in Ljubljana.